• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国帕金森病负担,1990-2019 年:2019 年全球疾病负担研究结果。

Burden of Parkinson Disease in China, 1990-2019: Findings from the 2019 Global Burden of Disease Study.

机构信息

Department of Neurology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, China.

Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Neuroepidemiology. 2023;57(1):51-64. doi: 10.1159/000527372. Epub 2022 Oct 26.

DOI:10.1159/000527372
PMID:36288688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10064393/
Abstract

INTRODUCTION

China has the most people with Parkinson disease (PD) in the world and is estimated to have over half of the worldwide PD population. The objective of this study was to analyze the corresponding burden of PD in China for the past decades.

METHOD

Data on disease burden related to PD in China were retrieved from the Global Burden of Disease (GBD) 2019 study. The estimated annual percentage changes (EAPCs) were calculated to assess temporal trends, and the ratio of years lived with disability (YLDs) to disability-adjusted life years (DALYs) was used as an index to evaluate the healthcare system.

RESULT

Nationally, the burden of PD increased from 1990 to 2019. Although the age-standardized incidence rate (ASIR) increased, the age-standardized death rate (ASDR) and age-standardized DALY rate both decreased. Age-standardized rates of PD in males remained higher than those in females, but trends in ASDR and the age-standardized DALY rate for females showed a pronounced decrease. The most remarkable increase in the ASIR was in individuals aged 45-49 years, with an EAPC of 1.74 (95% confidence interval, 1.26-2.21). The YLDs:DALYs ratio continuously increased compared with global figures and even with countries with high sociodemographic index (SDI).

CONCLUSION

Although ASDR and age-standardized DALY rates for PD have been declining, the burden of PD still needs attention as the total numbers have increased over the period. Generally, the greater burden of PD was in males. A sound health system with services tailored to PD continues to be required in the future.

摘要

简介

中国是世界上帕金森病(PD)患者最多的国家,据估计,全球 PD 患者中有一半以上在中国。本研究旨在分析过去几十年中国 PD 的相应负担。

方法

从全球疾病负担(GBD)2019 研究中检索了中国 PD 相关疾病负担的数据。计算了估计的年变化百分比(EAPC)以评估时间趋势,并使用残疾调整生命年(DALY)中残疾生命年(YLD)的比例作为评估医疗保健系统的指标。

结果

从 1990 年到 2019 年,全国 PD 负担增加。尽管年龄标准化发病率(ASIR)增加,但年龄标准化死亡率(ASDR)和年龄标准化 DALY 率均下降。男性的年龄标准化 PD 率仍然高于女性,但女性的 ASDR 和年龄标准化 DALY 率趋势呈明显下降。ASIR 增幅最大的是 45-49 岁的人群,EAPC 为 1.74(95%置信区间,1.26-2.21)。与全球数据相比,YLDs:DALYs 比值连续增加,甚至与高社会人口指数(SDI)国家相比也是如此。

结论

尽管 PD 的 ASDR 和年龄标准化 DALY 率一直在下降,但由于该时期的总人数增加,PD 的负担仍需要引起关注。一般来说,PD 的负担更大的是男性。未来仍需要有针对性的服务的健全卫生系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/9d321e47b1f3/ned-0057-0051-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/85063518eb07/ned-0057-0051-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/587ab3afac1c/ned-0057-0051-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/3d5f21f5ace9/ned-0057-0051-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/7b1eddaa6872/ned-0057-0051-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/3cb36c70c9ae/ned-0057-0051-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/b695620ebc29/ned-0057-0051-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/9d321e47b1f3/ned-0057-0051-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/85063518eb07/ned-0057-0051-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/587ab3afac1c/ned-0057-0051-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/3d5f21f5ace9/ned-0057-0051-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/7b1eddaa6872/ned-0057-0051-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/3cb36c70c9ae/ned-0057-0051-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/b695620ebc29/ned-0057-0051-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7015/10064393/9d321e47b1f3/ned-0057-0051-g07.jpg

相似文献

1
Burden of Parkinson Disease in China, 1990-2019: Findings from the 2019 Global Burden of Disease Study.中国帕金森病负担,1990-2019 年:2019 年全球疾病负担研究结果。
Neuroepidemiology. 2023;57(1):51-64. doi: 10.1159/000527372. Epub 2022 Oct 26.
2
Global burden of thyroid cancer from 1990 to 2021: a systematic analysis from the Global Burden of Disease Study 2021.全球 1990 年至 2021 年甲状腺癌负担:2021 年全球疾病负担研究的系统分析。
J Hematol Oncol. 2024 Aug 27;17(1):74. doi: 10.1186/s13045-024-01593-y.
3
Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017.全球、区域和国家层面精神分裂症发病率和伤残调整寿命年趋势:来自 2017 年全球疾病负担研究的结果。
Epidemiol Psychiatr Sci. 2020 Jan 13;29:e91. doi: 10.1017/S2045796019000891.
4
Global, Regional, and National Burden of Ischemic Stroke, 1990-2019.全球、区域和国家缺血性脑卒中负担,1990-2019 年。
Neurology. 2022 Jan 18;98(3):e279-e290. doi: 10.1212/WNL.0000000000013115. Epub 2021 Dec 15.
5
Global burden for dengue and the evolving pattern in the past 30 years.登革热的全球负担及过去30年的演变模式。
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab146.
6
The necessity for popularizing varicella-zoster virus vaccine programs worldwide: An age-period-cohort analysis for the Global Burden of Disease study 2019.在全球范围内推广水痘带状疱疹病毒疫苗项目的必要性:基于 2019 年全球疾病负担研究的年龄-时期-队列分析。
J Infect Public Health. 2023 Jul;16(7):1093-1101. doi: 10.1016/j.jiph.2023.05.016. Epub 2023 May 15.
7
Trends in the incidence and DALYs of anxiety disorders at the global, regional, and national levels: Estimates from the Global Burden of Disease Study 2019.全球、区域和国家层面焦虑障碍发病率和伤残损失生命年趋势:来自 2019 年全球疾病负担研究的估计。
J Affect Disord. 2022 Jan 15;297:83-93. doi: 10.1016/j.jad.2021.10.022. Epub 2021 Oct 20.
8
Global incidence, prevalence, and disability of vertebral fractures: a systematic analysis of the global burden of disease study 2019.全球椎体骨折的发病率、患病率和残疾负担:2019 年全球疾病负担研究的系统分析。
Spine J. 2022 May;22(5):857-868. doi: 10.1016/j.spinee.2021.12.007. Epub 2021 Dec 11.
9
Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.全球、区域和国家层面气管、支气管和肺癌的流行病学趋势:一项基于人群的研究。
J Hematol Oncol. 2020 Jul 20;13(1):98. doi: 10.1186/s13045-020-00915-0.
10
The burden of brain and central nervous system cancers in Asia from 1990 to 2019 and its predicted level in the next twenty-five years : Burden and prediction model of CNS cancers in Asia.1990 年至 2019 年亚洲脑和中枢神经系统癌症负担及其未来 25 年的预测水平:亚洲中枢神经系统癌症负担和预测模型。
BMC Public Health. 2023 Dec 16;23(1):2522. doi: 10.1186/s12889-023-17467-w.

引用本文的文献

1
Global trends of early-onset Parkinson's disease from 1990 to 2021, and projections until to 2030: a systematic analysis of the global burden of disease study 2021.1990年至2021年早发性帕金森病的全球趋势及至2030年的预测:全球疾病负担研究2021的系统分析
Front Neurol. 2025 Aug 1;16:1589760. doi: 10.3389/fneur.2025.1589760. eCollection 2025.
2
Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives.帕金森病中的左旋多巴与植物源生物活性化合物:作用机制、疗效及未来展望
CNS Neurosci Ther. 2025 Aug;31(8):e70540. doi: 10.1111/cns.70540.
3
Mapping the global burden of early-onset Parkinson's disease: socioeconomic and regional inequalities from the Global Burden of Disease Study 2021.

本文引用的文献

1
The quality of life in patients with Parkinson's disease: Focus on gender difference.帕金森病患者的生活质量:关注性别差异。
Brain Behav. 2022 Mar;12(3):e2517. doi: 10.1002/brb3.2517. Epub 2022 Feb 9.
2
Reduced Impact of Endovascular Thrombectomy on Disability in Real-World Practice, Relative to Randomized Controlled Trial Evidence in Australia.与澳大利亚随机对照试验证据相比,血管内血栓切除术在实际临床实践中对残疾的影响降低。
Front Neurol. 2020 Dec 8;11:593238. doi: 10.3389/fneur.2020.593238. eCollection 2020.
3
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
绘制早发性帕金森病的全球负担:基于《2021年全球疾病负担研究》的社会经济和地区不平等情况
Front Public Health. 2025 Jul 22;13:1618533. doi: 10.3389/fpubh.2025.1618533. eCollection 2025.
4
Illness acceptance and community self-efficacy mediate the relationship between social isolation and loneliness among elderly people with parkinson's disease.疾病接纳度和社区自我效能感在帕金森病老年患者的社会隔离与孤独感之间起中介作用。
Sci Rep. 2025 Jul 1;15(1):21554. doi: 10.1038/s41598-025-07890-x.
5
Reduced Risk of Benign Paroxysmal Positional Vertigo in Patients with Parkinson's Disease: A Nationwide Korean Cohort Study.帕金森病患者良性阵发性位置性眩晕风险降低:一项韩国全国队列研究
Healthcare (Basel). 2025 May 14;13(10):1145. doi: 10.3390/healthcare13101145.
6
NDDRF 2.0: An update and expansion of risk factor knowledge base for personalized prevention of neurodegenerative diseases.神经退行性疾病个性化预防风险因素知识库2.0:更新与扩展
Alzheimers Dement. 2025 May;21(5):e70282. doi: 10.1002/alz.70282.
7
Comparing the efficacy and safety of safinamide with rasagiline in China Parkinson's disease patients with a matching adjusted indirect comparison.在中国帕金森病患者中,采用匹配调整间接比较法比较沙芬酰胺与雷沙吉兰的疗效和安全性。
Sci Rep. 2025 Mar 26;15(1):10502. doi: 10.1038/s41598-025-94960-9.
8
Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson's disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation.溶血磷脂酰胆碱促进帕金森病中α-突触核蛋白聚集:破坏葡糖脑苷脂酶糖基化和溶酶体α-突触核蛋白降解。
NPJ Parkinsons Dis. 2025 Mar 15;11(1):47. doi: 10.1038/s41531-025-00902-7.
9
Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021.到2050年195个国家和地区帕金森病患病率及其驱动因素的预测:2021年全球疾病负担研究的建模研究
BMJ. 2025 Mar 5;388:e080952. doi: 10.1136/bmj-2024-080952.
10
Temporal and geographical dynamics of early-onset Parkinson's disease burden: insights from the Global Burden of Disease Study 2021.早发性帕金森病负担的时间和地理动态:来自《2021年全球疾病负担研究》的见解
Front Neurol. 2025 Jan 30;16:1473548. doi: 10.3389/fneur.2025.1473548. eCollection 2025.
204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
4
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1950-2019 年全球年龄性别特定生育率、死亡率、健康期望寿命(HALE)和人口估计值:2019 年全球疾病负担研究的综合人口分析。
Lancet. 2020 Oct 17;396(10258):1160-1203. doi: 10.1016/S0140-6736(20)30977-6.
5
[Disease burden on falls among 0-19 years old population in China, in 1990 and 2017].[1990年和2017年中国0至19岁人群跌倒的疾病负担]
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Nov 10;40(11):1363-1368. doi: 10.3760/cma.j.issn.0254-6450.2019.11.005.
6
Parkinson's disease in China: a forty-year growing track of bedside work.中国的帕金森病:四十年床边工作的发展轨迹
Transl Neurodegener. 2019 Jul 31;8:22. doi: 10.1186/s40035-019-0162-z. eCollection 2019.
7
The burden of care and the understanding of disease in Parkinson's disease.帕金森病的照料负担和疾病认知。
PLoS One. 2019 May 31;14(5):e0217581. doi: 10.1371/journal.pone.0217581. eCollection 2019.
8
Burden of neurodegenerative diseases in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease Study 2016.1990-2016 年东地中海区域神经退行性疾病负担:2016 年全球疾病负担研究的结果。
Eur J Neurol. 2019 Oct;26(10):1252-1265. doi: 10.1111/ene.13972. Epub 2019 May 31.
9
Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson's Disease Incidence.鱼藤酮敏感性的性别差异反映了人类帕金森病发病率的男女性别比例。
Toxicol Sci. 2019 Jul 1;170(1):133-143. doi: 10.1093/toxsci/kfz082.
10
Reflection on modern methods: years of life lost due to premature mortality-a versatile and comprehensive measure for monitoring non-communicable disease mortality.反思现代方法:因过早死亡而损失的寿命年——监测非传染性疾病死亡率的一种通用和全面的指标。
Int J Epidemiol. 2019 Aug 1;48(4):1367-1376. doi: 10.1093/ije/dyy254.